By Sean J. Morrison and Gerald J. Spangrude – The Salt Lake Tribune –
The people of Utah are at risk of being harmed by a law that undermines federal regulation and promotes the sale of unproven therapies.
On May 1, Utah’s law SB 199, Placental Tissue Amendments, goes into effect. Despite the innocuous-sounding name, this law puts the people of Utah at risk by promoting the sale of unproven placental “stem cell” products that are not approved by the Food and Drug Administration (FDA). The Legislature thus endorsed the idea that the safety and effectiveness of medical products need not be proven before sale to the people of Utah.
